LIS

First Two US labs Go Live with X-Lab's Labgnostic: the World's First Agnostic Laboratory Exchange Network

Retrieved on: 
Monday, May 22, 2023
Workflow, EMR, Laboratory information management system, Patient, Laboratory, LIS, News, Infineon TriCore, Fine chemical, Drug, Mail, Bookkeeping

LEEDS, England, ALBUQUERQUE, N.M. and LITTLE ROCK, Ark. , May 22, 2023 /PRNewswire/ -- Today, X-Lab, a UK-based company who owns and operates a systems-agnostic laboratory exchange hub, called Labgnostic, went 'live' in connecting their first two US labs to the network. New Mexico-based TriCore and Arkansas-based Arkana Labs are the first two labs to join the lab-to-lab service and experience faster turnaround times, improved efficiency, cost-effectiveness, and patient-safety.

Key Points: 
  • , May 22, 2023 /PRNewswire/ -- Today, X-Lab, a UK-based company who owns and operates a systems-agnostic laboratory exchange hub, called Labgnostic, went 'live' in connecting their first two US labs to the network.
  • New Mexico-based TriCore and Arkansas-based Arkana Labs are the first two labs to join the lab-to-lab service and experience faster turnaround times, improved efficiency, cost-effectiveness, and patient-safety.
  • On the news of the "Go Live", X-Lab's CEO, Mat Barrow, said:  "We're excited about the go-live between TriCore and Arkana.
  • As more labs join the network, the possibilities of what Labgnostic can offer to the US market will only grow stronger."

Arkana Labs Go-Live on the World's First Systems-Agnostic Laboratory Exchange Network; X-Lab's Labgnostic

Retrieved on: 
Monday, May 22, 2023
Laboratory, Workflow, EMR, Patient, LIS, News, Drug

LITTLE ROCK, Ark. , May 22, 2023 /PRNewswire/ -- Today, Arkana Labs, a renal pathology specialty lab based in Little Rock, Arkansas, became one of the first two labs to go live with Labgnostic in the US. Arkana, together with Tricore, an independent reference testing laboratory in Albequerque, New Mexico is poised to transition their existing paper-based orders and results workflows to fully electronic workflows.

Key Points: 
  • , May 22, 2023 /PRNewswire/ -- Today, Arkana Labs, a renal pathology specialty lab based in Little Rock, Arkansas, became one of the first two labs to go live with Labgnostic in the US.
  • Arkana, together with Tricore, an independent reference testing laboratory in Albequerque, New Mexico is poised to transition their existing paper-based orders and results workflows to fully electronic workflows.
  • Electronic interfacing enables orders and results to be sent between referring labs and performing labs without the need for manual entry of orders and results.
  • As more labs join the network, the possibilities of what Labgnostic can offer to the US market will only grow stronger."

Roche introduces navify® Sample Tracking for labs to track patient test samples before even reaching lab premises

Retrieved on: 
Monday, May 22, 2023
Analytics, Diagnosis, Health, Urine, ROG, RO, Phlebotomy, Collection, Laboratory, Patient, Control, LIS, PPA, Labs, Fine chemical, Television, Medical device

At Worldlab-EuroMedLab, Roche presents navify® Sample Tracking, a digital solution allowing labs to connect to innovative applications that monitor quality and detect errors in patient test samples along the entire journey to the lab.

Key Points: 
  • At Worldlab-EuroMedLab, Roche presents navify® Sample Tracking, a digital solution allowing labs to connect to innovative applications that monitor quality and detect errors in patient test samples along the entire journey to the lab.
  • navify Sample Tracking is part of the navify® Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.
  • The pathway to disease diagnosis requires tracking a patient's diagnostic sample from start to finish to support clinical decisions.
  • Roche is moderating key presentations about digital technologies with lab leaders and external digital ecosystems collaborators focusing on topics such as:

Paige Introduces Advanced Integration Capabilities to the Paige Platform, A Single Solution that Integrates the Entire Digital Pathology Ecosystem and Streamlines Workflows

Retrieved on: 
Thursday, May 18, 2023
Technology, Other Technology, Health Technology, Software, Internet, Health, General Health, Data Management, Artificial Intelligence, Workflow, ISO, Marie Cassidy, API, Pathology, Certification, UKCA, WSI, LIS, GDPR, FDA, HIPAA, Medical imaging, Video game

Paige , a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, today introduced new advanced integration capabilities to the Paige Platform, a holistic web-based solution that enables complete digital pathology workflows and supports the evolving needs of today’s modern lab.

Key Points: 
  • Paige , a global leader in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, today introduced new advanced integration capabilities to the Paige Platform, a holistic web-based solution that enables complete digital pathology workflows and supports the evolving needs of today’s modern lab.
  • With Paige’s flexible platform at the nexus of the digital pathology ecosystem, labs and pathologists can connect their existing and future digital pathology applications into a single environment managed by Paige.
  • In addition to integrating within the workflow, the solution enables seamless access to both Paige’s AI solutions and third-party AI applications.
  • “Paige is the only AI-powered digital pathology platform being used daily all over the world that offers truly open, secure and scalable API capabilities.

FORECLOSURE ACTIVITY NATIONWIDE SHOWS SLIGHT DECLINE IN APRIL 2023

Retrieved on: 
Thursday, May 11, 2023
Database, REO, Housing, NTS, REO Motor Car Company, File, NOD, NFS, Real estate owned, LIS, Foreclosure, Commercial property, Maid service

IRVINE, Calif., May 11, 2023 /PRNewswire/ -- ATTOM, a leading curator of land, property, and real estate data, today released its April 2023 U.S. Foreclosure Market Report, which shows there were a total of 32,977 U.S. properties with foreclosure filings — default notices, scheduled auctions or bank repossessions — down 10 percent from a month ago but up 8 percent from a year ago.

Key Points: 
  • Nationwide one in every 4,234 housing units had a foreclosure filing in April 2023.
  • "Foreclosure activity continues to stabilize and even correct itself in 2023, with April showing a 10 percent decrease in overall activity after a 20 percent increase last month," said Rob Barber, chief executive officer at ATTOM.
  • However, this trend underscores the significance of monitoring foreclosure rates and identifying any potential market shifts or trends."
  • Those major metropolitan areas with a population greater than 1 million that had the greatest number of foreclosure starts in April 2023 included: New York, NY (1,711 foreclosure starts); Chicago, IL (1,153 foreclosure starts); Miami, FL (846 foreclosure starts); Los Angeles, CA (829 foreclosure starts); and Philadelphia, PA (747 foreclosure starts).

Paige and Visiopharm Work Together to Deliver Advanced AI Cancer Diagnostic Support Through the Paige Platform

Retrieved on: 
Thursday, May 4, 2023
Health, Technology, Other Technology, Software, General Health, Networks, Artificial Intelligence, Heart, Partnership, Marie Cassidy, Deep learning, Pathology, Intelligence, Biomarker, IHC, Patient, LIS, Entrepreneurship, Digital, AI, Medical device, Medical imaging

“With this partnership, Paige is furthering our aim to provide the richest portfolio of AI applications delivered through a single platform.

Key Points: 
  • “With this partnership, Paige is furthering our aim to provide the richest portfolio of AI applications delivered through a single platform.
  • With AI from Visiopharm and Paige together on a single platform, these labs can have streamlined access to digital images and combined insights together in one place.
  • Dr. Michael Grunkin, CEO of Visiopharm, stated, "Visiopharm, a global leader in AI-driven precision pathology, delivers standardized decision support for complex tissue biomarkers.
  • Designed to work across various technologies and providers, we join Paige in our commitment to making this technology accessible worldwide on top pathology platforms."

Ryan Chappelle Joins NovoPath as SVP of Sales, Citing Forward Innovation in Pathology Informatics and Cloud as Key Motivation

Retrieved on: 
Friday, April 28, 2023
Informatics, LIS, Pathology, Growth, Software as a service, Sunquest Information Systems, Senior, Software

Chappelle brings over 20 years of experience in healthcare technology sales and management to his new role at NovoPath.

Key Points: 
  • Chappelle brings over 20 years of experience in healthcare technology sales and management to his new role at NovoPath.
  • Chappelle's decision to join NovoPath was motivated by the company's forward-thinking approach to pathology informatics and cloud technology.
  • NovoPath CEO, Promise Okeke, added: "We are excited to welcome Ryan to the NovoPath team.
  • We look forward to working with Ryan to drive continued growth and success for NovoPath."

SYNERGEN Health and PreciseMDX Announce Strategic Partnership to Provide Best-in-Class Digital Revenue Cycle Solution & Services to Fuel Laboratory Growth

Retrieved on: 
Thursday, April 20, 2023
Technology, Hospitals, Security, Health Technology, Software, Practice Management, Health, Electronic Design Automation, Data Management, Insurance, Partnership, RCM, Partner (business rank), LBMS, Patient, EHR, Laboratory, LIS, Growth, Entrepreneurship, KPI-driven code analysis, Fine chemical

PreciseMDX provides lab businesses with a streamlined digital experience for testing and population health management , creating a seamless consumer experience while enhancing business intelligence and reducing costs.

Key Points: 
  • PreciseMDX provides lab businesses with a streamlined digital experience for testing and population health management , creating a seamless consumer experience while enhancing business intelligence and reducing costs.
  • Under the partnership, SYNERGEN Health's comprehensive revenue cycle management services will be integrated with PreciseMDX's enterprise Lab Business Management Solution (LBMS).
  • Combined, SYNERGEN Health and PreciseMDX will drive measurable value for clients by implementing sustainable improvements that reduce costs, maximize cash flow, and enhance the patient-provider experience.
  • "Together with PreciseMDX, we’re offering labs the best digital revenue cycle management solution in the market, capable of improving financial performance and focusing on delivering high-quality patient care.

Meridian Bioscience Announces FDA Clearance for Innovative Curian® Shiga Toxin Assay

Retrieved on: 
Wednesday, April 19, 2023
HUS, STEC, Human, Subjectivity, Workflow, Syndrome, Infection, Campylobacter, Shiga toxin, STX1A, Patient, LIS, FDA, GI, Pharmaceutical industry, Meridian

CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.

Key Points: 
  • CINCINNATI, April 19, 2023 /PRNewswire/ -- Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration (FDA) had granted clearance for the company's new Curian® Shiga Toxin assay.
  • This assay joins Curian HpSA® and Curian Campy as Meridian expands its Curian diagnostic platform to maintain leadership in the gastrointestinal disease testing market.
  • The Curian Shiga Toxin assay is designed for use with the Curian analyzer.
  • The new assay is a rapid, qualitative, fluorescent immunoassay for the simultaneous detection and differentiation of Shiga toxin 1 (Stx1) and Shiga toxin 2 (Stx2) in a single test device.

NovoPath Named Winner in MedHealth Outlook's 2023 Lab Management Solution Providers List

Retrieved on: 
Friday, April 14, 2023
Workload, LIS, Patient, Laboratory, Patient safety, Software, Television, Medical device, Fine chemical

BRIDGEWATER, N.J., April 14, 2023 /PRNewswire/ -- NovoPath, a leading provider of LIS (laboratory information systems) solutions, has been named as a winner in the 2023 Lab Management Solution Providers list by MedHealth Outlook.

Key Points: 
  • BRIDGEWATER, N.J., April 14, 2023 /PRNewswire/ -- NovoPath, a leading provider of LIS (laboratory information systems) solutions, has been named as a winner in the 2023 Lab Management Solution Providers list by MedHealth Outlook.
  • The annual list recognizes companies that are transforming the healthcare industry through their innovative lab management solutions.
  • NovoPath was selected for its cutting-edge LIS software and interoperability solutions that enable laboratories to improve workflow efficiency, accuracy, and patient safety.
  • "We are thrilled to be recognized as a top lab management solution provider by MedHealth Outlook," said Promise Okeke, CEO of NovoPath.